Custom Drug Intermediates-Global Market Status and Trend Report 2016-2026

Table of Contents

Chapter 1 Overview of Custom Drug Intermediates

• 1.1 Definition of Custom Drug Intermediates in This Report
• 1.2 Commercial Types of Custom Drug Intermediates
  • 1.2.1 GMP
  • 1.2.2 Non-GMP
• 1.3 Downstream Application of Custom Drug Intermediates
  • 1.3.1 Antibiotics
  • 1.3.2 Antipyretic Analgesics
  • 1.3.3 Vitamins
  • 1.3.4 Others
• 1.4 Development History of Custom Drug Intermediates
• 1.5 Market Status and Trend of Custom Drug Intermediates 2016-2026
  • 1.5.1 Global Custom Drug Intermediates Market Status and Trend 2016-2026
  • 1.5.2 Regional Custom Drug Intermediates Market Status and Trend 2016-2026

Chapter 2 Global Market Status and Forecast by Regions

• 2.1 Market Development of Custom Drug Intermediates 2016-2021
• 2.2 Production Market of Custom Drug Intermediates by Regions
  • 2.2.1 Production Volume of Custom Drug Intermediates by Regions
  • 2.2.2 Production Value of Custom Drug Intermediates by Regions
• 2.3 Demand Market of Custom Drug Intermediates by Regions
• 2.4 Production and Demand Status of Custom Drug Intermediates by Regions
  • 2.4.1 Production and Demand Status of Custom Drug Intermediates by Regions 2016-2021
  • 2.4.2 Import and Export Status of Custom Drug Intermediates by Regions 2016-2021

Chapter 3 Global Market Status and Forecast by Types

• 3.1 Production Volume of Custom Drug Intermediates by Types
• 3.2 Production Value of Custom Drug Intermediates by Types
• 3.3 Market Forecast of Custom Drug Intermediates by Types

Chapter 4 Global Market Status and Forecast by Downstream Industry

• 4.1 Demand Volume of Custom Drug Intermediates by Downstream Industry
• 4.2 Market Forecast of Custom Drug Intermediates by Downstream Industry

Chapter 5 Market Driving Factor Analysis of Custom Drug Intermediates

• 5.1 Global Economy Situation and Trend Overview
• 5.2 Custom Drug Intermediates Downstream Industry Situation and Trend Overview

Chapter 6 Custom Drug Intermediates Market Competition Status by Major Manufacturers

• 6.1 Production Volume of Custom Drug Intermediates by Major Manufacturers
• 6.2 Production Value of Custom Drug Intermediates by Major Manufacturers
• 6.3 Basic Information of Custom Drug Intermediates by Major Manufacturers
  • 6.3.1 Headquarters Location and Established Time of Custom Drug Intermediates Major Manufacturer
  • 6.3.2 Employees and Revenue Level of Custom Drug Intermediates Major Manufacturer
• 6.4 Market Competition News and Trend
  • 6.4.1 Merger, Consolidation or Acquisition News
  • 6.4.2 Investment or Disinvestment News
  • 6.4.3 New Product Development and Launch

Chapter 7 Custom Drug Intermediates Major Manufacturers Introduction and Market Data

• 7.1 Lonza
  • 7.1.1 Company profile
  • 7.1.2 Representative Custom Drug Intermediates Product
  • 7.1.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Lonza
• 7.2 Catalent
  • 7.2.1 Company profile
  • 7.2.2 Representative Custom Drug Intermediates Product
  • 7.2.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Catalent
• 7.3 Patheon
  • 7.3.1 Company profile
  • 7.3.2 Representative Custom Drug Intermediates Product
  • 7.3.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Patheon
• 7.4 Jubilant
  • 7.4.1 Company profile
  • 7.4.2 Representative Custom Drug Intermediates Product
  • 7.4.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Jubilant
• 7.5 Granules
  • 7.5.1 Company profile
  • 7.5.2 Representative Custom Drug Intermediates Product
  • 7.5.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Granules
• 7.6 Ganesh
  • 7.6.1 Company profile
  • 7.6.2 Representative Custom Drug Intermediates Product
  • 7.6.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Ganesh
• 7.7 Chemcon
  • 7.7.1 Company profile
  • 7.7.2 Representative Custom Drug Intermediates Product
  • 7.7.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Chemcon
• 7.8 BASF
  • 7.8.1 Company profile
  • 7.8.2 Representative Custom Drug Intermediates Product
  • 7.8.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of BASF
• 7.9 Porton
  • 7.9.1 Company profile
  • 7.9.2 Representative Custom Drug Intermediates Product
  • 7.9.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Porton
• 7.10 Lianhetech
  • 7.10.1 Company profile
  • 7.10.2 Representative Custom Drug Intermediates Product
  • 7.10.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Lianhetech
• 7.11 ABA Chem
  • 7.11.1 Company profile
  • 7.11.2 Representative Custom Drug Intermediates Product
  • 7.11.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of ABA Chem
• 7.12 Tianma
  • 7.12.1 Company profile
  • 7.12.2 Representative Custom Drug Intermediates Product
  • 7.12.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Tianma
• 7.13 Jiujiujiu
  • 7.13.1 Company profile
  • 7.13.2 Representative Custom Drug Intermediates Product
  • 7.13.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Jiujiujiu
• 7.14 Alpha
  • 7.14.1 Company profile
  • 7.14.2 Representative Custom Drug Intermediates Product
  • 7.14.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Alpha
• 7.15 Jiuzhou
  • 7.15.1 Company profile
  • 7.15.2 Representative Custom Drug Intermediates Product
  • 7.15.3 Custom Drug Intermediates Sales, Revenue, Price and Gross Margin of Jiuzhou
• 7.16 Yongtai

Chapter 8 Upstream and Downstream Market Analysis of Custom Drug Intermediates

• 8.1 Industry Chain of Custom Drug Intermediates
• 8.2 Upstream Market and Representative Companies Analysis
• 8.3 Downstream Market and Representative Companies Analysis

Chapter 9 Cost and Gross Margin Analysis of Custom Drug Intermediates

• 9.1 Cost Structure Analysis of Custom Drug Intermediates
• 9.2 Raw Materials Cost Analysis of Custom Drug Intermediates
• 9.3 Labor Cost Analysis of Custom Drug Intermediates
• 9.4 Manufacturing Expenses Analysis of Custom Drug Intermediates

Chapter 10 Marketing Status Analysis of Custom Drug Intermediates

• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
  • 10.1.3 Marketing Channel Development Trend
• 10.2 Market Positioning
  • 10.2.1 Pricing Strategy
  • 10.2.2 Brand Strategy
  • 10.2.3 Target Client
• 10.3 Distributors/Traders List

Chapter 11 Report Conclusion

Chapter 12 Research Methodology and Reference

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources